Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

被引：0
|
作者：
Jaime Antonio Oliver
Raúl Ortiz
Consolación Melguizo
Pablo Juan Álvarez
Jaime Gómez-Millán
Jose Prados
机构：
[1] University of Granada,Institute of Biopathology and Regenerative Medicine (IBIMER)
[2] University of Jaén,Department of Health Sciences
[3] SAS-Universidad de Granada,Biosanitary Institute of Granada (ibs.GRANADA)
[4] University of Granada,Department of Anatomy and Embryology
[5] Hospital Clinico Universitario Virgen de la Victoria,Radiation Oncology Department
来源：
BMC Cancer | / 14卷
关键词：
Colorectal cancer; MGMT; CD133; Methylation status; Biomarker; Overall survival; Disease free-survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
    Antonio Oliver, Jaime
    Ortiz, Raul
    Melguizo, Consolacion
    Juan Alvarez, Pablo
    Gomez-Millan, Jaime
    Prados, Jose
    [J]. BMC CANCER, 2014, 14
  • [2] MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
    Consolación Melguizo
    Jose Prados
    Beatriz González
    Raul Ortiz
    Angel Concha
    Pablo Juan Alvarez
    Roberto Madeddu
    Gloria Perazzoli
    Jaime Antonio Oliver
    Rodrigo López
    Fernando Rodríguez-Serrano
    Antonia Aránega
    [J]. Journal of Translational Medicine, 10
  • [3] MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
    Melguizo, Consolacion
    Prados, Jose
    Gonzalez, Beatriz
    Ortiz, Raul
    Concha, Angel
    Juan Alvarez, Pablo
    Madeddu, Roberto
    Perazzoli, Gloria
    Antonio Oliver, Jaime
    Lopez, Rodrigo
    Rodriguez-Serrano, Fernando
    Aranega, Antonia
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [4] MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
    Gonzalez-Astorga, B.
    Luque, R.
    Castellon, V.
    Gonzalez, E.
    Sanchez, C.
    Soberino, J.
    Gonzalez, C.
    Ruiz, J.
    Zurita, M.
    Delgado, J. R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S794 - S794
  • [5] THE CORRELATION AND PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER METHYLATION AND MGMT PROTEIN IN GLIOBLASTOMAS
    Cao, Van Thang
    Lung, Tae-Young
    Jung, Shin
    Jin, Shu-Guang
    Moon, Kyung-Sub
    Kim, In-Young
    Kang, Sam-Suk
    Park, Chang-Soo
    Lee, Kyung-Hwa
    Chae, Hong-Jae
    [J]. NEUROSURGERY, 2009, 65 (05) : 866 - 875
  • [6] THE CORRELATION AND PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER METHYLATION AND THE MGMT PROTEIN IN GLIOBLASTOMAS
    Jung, Tae-Young
    Cao, Van Thang
    Jung, Shin
    Jin, Shu-Guang
    Moon, Kyung-Sub
    Kim, In-Young
    Kang, Sam-Suk
    Park, Chang-Soo
    Lee, Kyung-Hwa
    [J]. NEURO-ONCOLOGY, 2009, 11 (06) : 944 - 944
  • [7] MGMT Promoter Methylation in Sporadic Colorectal Cancer
    Khatami, Fatemeh
    Mohebbi, Reza
    Malek, Fatemeh Nemati
    Ghiasi, Somayeh
    Haghighi, Mahdi Montazer
    Zali, Mahammad R.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 937 - 937
  • [8] THE CORRELATION AND PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER METHYLATION AND MGMT PROTEIN IN GLIOBLASTOMAS COMMENTS
    Chiocca, E. Antonio
    [J]. NEUROSURGERY, 2009, 65 (05) : 875 - 875
  • [9] Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
    Zappe, Katja
    Puehringer, Katharina
    Pflug, Simon
    Berger, Daniel
    Boehm, Andreas
    Spiegl-Kreinecker, Sabine
    Cichna-Markl, Margit
    [J]. CELLS, 2023, 12 (12)
  • [10] A CONTINUUM OF MGMT PROMOTER METHYLATION AND MGMT ACTIVITY
    Alshami, Jad
    Sabau, Carmen
    Sadr, Mohamad Seyed
    Anan, Mitsuhiro
    Sadr, Emad Seyed
    Sin, Vince
    Del Maestro, Rolando
    [J]. NEURO-ONCOLOGY, 2010, 12 : 17 - 17
12345